1 active not recruiting, 1 completed, 1 not yet recruiting. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Active not recruiting 1, Completed 1, Not yet recruiting 1 |
Follow Emblok, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Safety and Effectiveness of the EMBLOK EPS Compared With No Cerebral Embolic Protection During TAVR EMBLOK™ Embolic Protection System ("EMBLOK EPS") - AORTIC VALVE DISEASES, Aortic Valve Stenosis and/or Insufficiency | Not applicable | Not yet recruiting | Emblok, Inc. | 560 | 2025-10-21 | 2025-08-19 |
| Evaluation of Safety and Effectiveness of the EMBLOK EPS During TAVR EMBLOK™ Embolic Protection System ("EMBLOK EPS"), SENTINEL™ Cerebral Protection System - Aortic Valve Stenosis, Aortic Valve Disease | Not applicable | Active not recruiting | Emblok, Inc. | 532 | 2023-10-17 | 2025-08-06 |
| European Study Evaluating the EMBLOK Embolic Protection System During TAVR Transcatheter Aortic Valve Replacement (TAVR), EMBLOK filter - Aortic Valve Disease | Not applicable | Completed | Emblok, Inc. | 28 | 2017-03-08 | 2024-03-05 |
Aortic Valve Disease (3) · Aortic Valve Insufficiency (2) · Aortic Valve Stenosis (1)
Transcatheter Aortic Valve Replacement (1)
Italy (1) · United States (1)
Azeem Latib, MD (1) · Hemal Gada, MD (1)